Published • loading... • Updated
Ozempic and AI, the Recipe with Which Health Wants to Go Back on the Stock Exchange in 2026
Summary by El Pais
1 Articles
1 Articles
Everyone knows Ozempic, something unusual for a prescription drug. What is not so bright and circulates so much in networks is that the future of this drug, of its rivals to lose weight and of much of the health sector, will be played next week, at a congress in New Orleans, in the United States. There, between 5 and 8 June, the world’s leading pharmaceuticals will present their most recent data on the next generation of treatments against obesi…
·Spain
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left1Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
